Caxton Associates LLP Decreases Stock Holdings in Surgery Partners, Inc. $SGRY

Caxton Associates LLP reduced its position in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 43.5% in the second quarter, according to its most recent filing with the SEC. The fund owned 103,589 shares of the company’s stock after selling 79,594 shares during the quarter. Caxton Associates LLP owned about 0.08% of Surgery Partners worth $2,303,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of SGRY. AlphaQuest LLC lifted its position in Surgery Partners by 112.0% during the first quarter. AlphaQuest LLC now owns 1,058 shares of the company’s stock valued at $25,000 after purchasing an additional 559 shares during the last quarter. PNC Financial Services Group Inc. raised its position in shares of Surgery Partners by 86.4% during the 1st quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company’s stock valued at $28,000 after buying an additional 542 shares in the last quarter. Summit Securities Group LLC purchased a new stake in shares of Surgery Partners during the 1st quarter valued at about $31,000. FNY Investment Advisers LLC bought a new position in shares of Surgery Partners in the 2nd quarter valued at about $115,000. Finally, Tower Research Capital LLC TRC grew its position in Surgery Partners by 68.7% in the second quarter. Tower Research Capital LLC TRC now owns 9,313 shares of the company’s stock worth $207,000 after acquiring an additional 3,794 shares in the last quarter.

Surgery Partners Stock Performance

Shares of Surgery Partners stock opened at $15.63 on Monday. The company has a quick ratio of 1.72, a current ratio of 1.88 and a debt-to-equity ratio of 1.10. The stock’s fifty day moving average is $18.84 and its two-hundred day moving average is $21.04. Surgery Partners, Inc. has a 52 week low of $14.94 and a 52 week high of $26.16. The company has a market capitalization of $2.02 billion, a PE ratio of -11.49 and a beta of 1.93.

Surgery Partners (NASDAQ:SGRY) last issued its earnings results on Monday, November 10th. The company reported $0.13 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.06). The company had revenue of $821.50 million for the quarter, compared to analysts’ expectations of $823.55 million. Surgery Partners had a negative net margin of 5.21% and a positive return on equity of 2.41%. The firm’s revenue for the quarter was up 6.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.19 earnings per share. As a group, analysts expect that Surgery Partners, Inc. will post 0.67 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages have issued reports on SGRY. Benchmark decreased their price objective on Surgery Partners from $35.00 to $30.00 and set a “buy” rating on the stock in a research report on Tuesday, November 11th. JPMorgan Chase & Co. decreased their price target on Surgery Partners from $27.00 to $20.00 and set a “neutral” rating on the stock in a report on Monday, November 24th. Barclays lowered their price target on Surgery Partners from $24.00 to $18.00 and set an “equal weight” rating for the company in a research report on Friday, November 21st. Weiss Ratings reiterated a “sell (d-)” rating on shares of Surgery Partners in a research report on Monday, December 8th. Finally, UBS Group lowered their target price on shares of Surgery Partners from $34.00 to $29.00 and set a “buy” rating for the company in a report on Thursday, November 13th. Seven investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Surgery Partners has a consensus rating of “Moderate Buy” and an average price target of $27.44.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.